You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 8, April 26, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Patient Safety/ Medical Error
 •Bacterial Infections
 •Review
 •Alert me on articles by topic

Catheter-Associated Infections

Pathogenesis Affects Prevention

Barbara W. Trautner, MD; Rabih O. Darouiche, MD

Arch Intern Med. 2004;164:842-850.

Intravascular catheters and urinary catheters are the 2 most commonly inserted medical devices in the United States, and they are likewise the two most common causes of nosocomially acquired bloodstream infection. Biofilm formation on the surfaces of indwelling catheters is central to the pathogenesis of infection of both types of catheters. The cornerstone to any preventive strategy of intravascular catheter infections is strict attention to infection control practices. Antimicrobial-impregnated intravascular catheters are a useful adjunction to infection control measures. Prevention of urinary catheter–associated infection is hindered by the numbers and types of organisms present in the periurethral area as well as by the typically longer duration of catheter placement. Antimicrobial agents in general have not been effective in preventing catheter-associated urinary tract infection in persons with long-term, indwelling urethral catheters. Preventive strategies that avoid the use of antimicrobial agents may be necessary in this population.


From the Department of Medicine, Infectious Diseases Section (Drs Trautner and Darouiche), and Department of Physical Medicine and Rehabilitation, Center for Prostheses Infection (Dr Darouiche), Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Tex. Dr Darouiche is an employee of Baylor College of Medicine, which has a licensing agreement with Cook Inc for coating of catheters with minocycline and rifampin.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Blocking of Bacterial Biofilm Formation by a Fish Protein Coating
Vejborg and Klemm
Appl. Environ. Microbiol. 2008;74:3551-3558.
ABSTRACT | FULL TEXT  

Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies
Boersma et al.
Ann Oncol 2008;19:433-442.
ABSTRACT | FULL TEXT  

Combination of Tigecycline and N-Acetylcysteine Reduces Biofilm-Embedded Bacteria on Vascular Catheters
Aslam et al.
Antimicrob. Agents Chemother. 2007;51:1556-1558.
ABSTRACT | FULL TEXT  

Effective Prevention of Microbial Biofilm Formation on Medical Devices by Low-Energy Surface Acoustic Waves
Hazan et al.
Antimicrob. Agents Chemother. 2006;50:4144-4152.
ABSTRACT | FULL TEXT  

Role of Silver Ions in Destabilization of Intermolecular Adhesion Forces Measured by Atomic Force Microscopy in Staphylococcus epidermidis Biofilms
Chaw et al.
Antimicrob. Agents Chemother. 2005;49:4853-4859.
ABSTRACT | FULL TEXT  

Intravesical Nitric Oxide Delivery for Prevention of Catheter-Associated Urinary Tract Infections
Carlsson et al.
Antimicrob. Agents Chemother. 2005;49:2352-2355.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.